CDC25 phosphatases play a critical role in the regulation of the cell cycle and thus represent attractive cancer therapeutic targets. We previously discovered the 4-(2-carboxybenzoyl)phthalic acid (NSC28620) as a new CDC25 inhibitor endowed with promising anticancer activity in breast, prostate, and leukemia cells. Herein, we report a structure-based optimization of NSC28620, leading to the identification of a series of novel naphthylphenylketone and naphthylphenylamine derivatives as CDC25B inhibitors. Compounds 7j, 7i, 6e, 7f, and 3 showed higher inhibitory activity than the initial lead, with Ki values in the low micromolar range. Kinetic analysis, intrinsic fluorescence studies, and induced fit docking simulations provided a mechanistic understanding of the activity of these derivatives. All compounds were tested in the highly aggressive human melanoma cell lines A2058 and A375. Compound 4a potently inhibited cell proliferation and colony formation, causing an increase of the G2/M phase and a reduction of the G0/G1 phase of the cell cycle in both cell lines

Discovery of Novel Naphthylphenylketone and Naphthylphenylamine Derivatives as Cell Division Cycle 25B (CDC25B) Phosphatase Inhibitors: Design, Synthesis, Inhibition Mechanism, and in Vitro Efficacy against Melanoma Cell Lines / Cerchia, Carmen; Nasso, Rosarita; Mori, Matteo; Villa, Stefania; Gelain, Arianna; Capasso, Alessandra; Aliotta, Federica; Simonetti, Martina; Rullo, Rosario; Masullo, Mariorosario; DE VENDITTIS, Emmanuele; Ruocco, MARIA ROSARIA; Lavecchia, Antonio. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 62:15(2019), pp. 7089-7110. [10.1021/acs.jmedchem.9b00632]

Discovery of Novel Naphthylphenylketone and Naphthylphenylamine Derivatives as Cell Division Cycle 25B (CDC25B) Phosphatase Inhibitors: Design, Synthesis, Inhibition Mechanism, and in Vitro Efficacy against Melanoma Cell Lines

Carmen Cerchia;Rosarita Nasso;Federica Aliotta;Emmanuele De Vendittis;Maria Rosaria Ruocco
;
Antonio Lavecchia
2019

Abstract

CDC25 phosphatases play a critical role in the regulation of the cell cycle and thus represent attractive cancer therapeutic targets. We previously discovered the 4-(2-carboxybenzoyl)phthalic acid (NSC28620) as a new CDC25 inhibitor endowed with promising anticancer activity in breast, prostate, and leukemia cells. Herein, we report a structure-based optimization of NSC28620, leading to the identification of a series of novel naphthylphenylketone and naphthylphenylamine derivatives as CDC25B inhibitors. Compounds 7j, 7i, 6e, 7f, and 3 showed higher inhibitory activity than the initial lead, with Ki values in the low micromolar range. Kinetic analysis, intrinsic fluorescence studies, and induced fit docking simulations provided a mechanistic understanding of the activity of these derivatives. All compounds were tested in the highly aggressive human melanoma cell lines A2058 and A375. Compound 4a potently inhibited cell proliferation and colony formation, causing an increase of the G2/M phase and a reduction of the G0/G1 phase of the cell cycle in both cell lines
2019
Discovery of Novel Naphthylphenylketone and Naphthylphenylamine Derivatives as Cell Division Cycle 25B (CDC25B) Phosphatase Inhibitors: Design, Synthesis, Inhibition Mechanism, and in Vitro Efficacy against Melanoma Cell Lines / Cerchia, Carmen; Nasso, Rosarita; Mori, Matteo; Villa, Stefania; Gelain, Arianna; Capasso, Alessandra; Aliotta, Federica; Simonetti, Martina; Rullo, Rosario; Masullo, Mariorosario; DE VENDITTIS, Emmanuele; Ruocco, MARIA ROSARIA; Lavecchia, Antonio. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 62:15(2019), pp. 7089-7110. [10.1021/acs.jmedchem.9b00632]
File in questo prodotto:
File Dimensione Formato  
2019 Discovery of Novel Naphthylphenylketone and Naphthylphenylamine .pdf

non disponibili

Descrizione: 2019. Journal of Medicinal Chemistry
Tipologia: Documento in Post-print
Licenza: Dominio pubblico
Dimensione 4.88 MB
Formato Adobe PDF
4.88 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/770927
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 12
social impact